Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC
Clinical trial NCT03219762 · UNKNOWN
Trial details
- NCT number
- NCT03219762
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-07
- Primary completion
- 2019-01-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.